Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today.

López-Muñoz F, Alamo C.

Curr Pharm Des. 2009;15(14):1563-86. Review.

PMID:
19442174
2.

Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part I: monoamine oxidase inhibitors.

López-Muñoz F, Alamo C, Juckel G, Assion HJ.

J Clin Psychopharmacol. 2007 Dec;27(6):555-9. No abstract available.

PMID:
18004120
3.

Mechanism of action of antidepressant medications.

Feighner JP.

J Clin Psychiatry. 1999;60 Suppl 4:4-11; discussion 12-3. Review.

4.

Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part II: tricyclics and tetracyclics.

Fangmann P, Assion HJ, Juckel G, González CA, López-Muñoz F.

J Clin Psychopharmacol. 2008 Feb;28(1):1-4. doi: 10.1097/jcp.0b013e3181627b60. No abstract available.

PMID:
18204333
5.

New approaches to antidepressant drug design: cytokine-regulated pathways.

Nishida A, Miyaoka T, Inagaki T, Horiguchi J.

Curr Pharm Des. 2009;15(14):1683-7. Review.

PMID:
19442181
6.

[Domino principle--monoamines in bottom-view].

Sümegi A.

Neuropsychopharmacol Hung. 2008 Jun;10(3):131-40. Review. Hungarian. Erratum in: Neuropsychopharmacol Hung. 2009 Sep;11(3):149.

7.

History and therapeutic use of MAO-A inhibitors: a historical perspective of mao-a inhibitors as antidepressant drug.

Yáñez M, Padín JF, Arranz-Tagarro JA, Camiña M, Laguna R.

Curr Top Med Chem. 2012;12(20):2275-82. Review.

PMID:
23231399
8.

New antidepressant drugs: beyond monoaminergic mechanisms.

Alamo C, López-Muñoz F.

Curr Pharm Des. 2009;15(14):1559-62. No abstract available.

PMID:
19442173
9.

Current status of antidepressants: clinical pharmacology and therapy.

Baldessarini RJ.

J Clin Psychiatry. 1989 Apr;50(4):117-26. Review.

PMID:
2647712
10.

Duloxetine pharmacology: profile of a dual monoamine modulator.

Karpa KD, Cavanaugh JE, Lakoski JM.

CNS Drug Rev. 2002 Winter;8(4):361-76. Review.

11.

Invited review: the evolution of antidepressant mechanisms.

Slattery DA, Hudson AL, Nutt DJ.

Fundam Clin Pharmacol. 2004 Feb;18(1):1-21. Review.

PMID:
14748749
12.

Psychobiology and psychopharmacotherapy of unipolar major depression: a review.

O'Toole SM, Johnson DA.

Arch Psychiatr Nurs. 1997 Dec;11(6):304-13. Review.

PMID:
9419922
13.
14.
15.

The effects of antidepressants on sleep: a review.

Gursky JT, Krahn LE.

Harv Rev Psychiatry. 2000 Dec;8(6):298-306. Review.

PMID:
11133824
16.

Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents.

Hill MN, Ho WS, Hillard CJ, Gorzalka BB.

J Neural Transm (Vienna). 2008 Dec;115(12):1673-9. doi: 10.1007/s00702-008-0131-7. Epub 2008 Oct 31. Erratum in: J Neural Transm. 2009 Feb;116(2):141.

17.

The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects.

Dell'Osso B, Palazzo MC, Oldani L, Altamura AC.

CNS Neurosci Ther. 2011 Dec;17(6):723-32. doi: 10.1111/j.1755-5949.2010.00217.x. Epub 2010 Dec 14. Review.

PMID:
21155988
18.

Role of norepinephrine in depression.

Delgado PL, Moreno FA.

J Clin Psychiatry. 2000;61 Suppl 1:5-12. Review.

19.

Enhancement of antidepressant potency by a potentiator of AMPA receptors.

Li X, Witkin JM, Need AB, Skolnick P.

Cell Mol Neurobiol. 2003 Jun;23(3):419-30.

PMID:
12825836
20.

Rational drug use in the treatment of depression.

Cohen LJ.

Pharmacotherapy. 1997 Jan-Feb;17(1):45-61. Review.

PMID:
9017765

Supplemental Content

Support Center